Intellia Therapeutics Inc (NTLA)
Healthcare
Biotechnology
10.70 $
-3.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Intellia Therapeutics Inc (NTLA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.0% of the shares are freely tradable; institutional investors hold 76.7%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
76.7%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
3.9%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
96.0%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
45.4%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
140Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Investment Management LLC | 10.38 | 14,509,247 | +2.1 | 03/31/2026 |
| Vanguard Group Inc | 9.31 | 13,010,001 | +17.8 | 12/31/2025 |
| BlackRock Inc | 8.70 | 12,155,806 | +18.3 | 03/31/2026 |
| State Street Corp | 4.95 | 6,922,676 | +7.8 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.45 | 6,223,325 | +0.0 | 03/31/2026 |
| D. E. Shaw & Co LP | 4.10 | 5,728,177 | +7.4 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.64 | 5,084,105 | +0.0 | 03/31/2026 |
| Two Sigma Investments LLC | 3.37 | 4,705,901 | +74.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Innovation ETF | 8.54 | 11,925,813 | +0.0 | 05/31/2026 |
| ARK Disruptive Innovation Full Composite | 6.66 | 9,307,927 | +3.7 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.